See more : Ginkgo Bioworks Holdings, Inc. WT (DNA-WT) Income Statement Analysis – Financial Results
Complete financial analysis of Krebs Biochemicals & Industries Limited (KREBSBIO.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Krebs Biochemicals & Industries Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Meltronix, Inc. (MTNX) Income Statement Analysis – Financial Results
- USI Corporation (1304.TW) Income Statement Analysis – Financial Results
- Radware Ltd. (RDWR) Income Statement Analysis – Financial Results
- Sun Life Financial Inc. (0VJA.L) Income Statement Analysis – Financial Results
- State Grid Yingda Co.,Ltd. (600517.SS) Income Statement Analysis – Financial Results
Krebs Biochemicals & Industries Limited (KREBSBIO.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://krebsbiochem.com
About Krebs Biochemicals & Industries Limited
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is headquartered in Hyderabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 504.22M | 521.34M | 597.03M | 386.06M | 235.84M | 371.33M | 254.09M | 16.95M | 12.90M | 0.00 | 707.60M | 724.45M | 462.34M | 511.98M | 506.95M |
| Cost of Revenue | 311.49M | 404.73M | 628.75M | 522.32M | 329.11M | 389.00M | 259.11M | 26.91M | 46.37M | 0.00 | 405.43M | 428.60M | 309.06M | 340.04M | 310.42M |
| Gross Profit | 192.73M | 116.61M | -31.71M | -136.26M | -93.27M | -17.67M | -5.02M | -9.96M | -33.47M | 0.00 | 302.17M | 295.85M | 153.28M | 171.94M | 196.52M |
| Gross Profit Ratio | 38.22% | 22.37% | -5.31% | -35.29% | -39.55% | -4.76% | -1.97% | -58.74% | -259.57% | 0.00% | 42.70% | 40.84% | 33.15% | 33.58% | 38.77% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 553.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 6.00M | 8.60M | 11.38M | 6.72M | 8.41M | 11.76M | 9.11M | 7.60M | 605.00K | 0.00 | 244.93M | 192.20M | 66.32M | 34.84M | 43.08M |
| Selling & Marketing | 0.00 | 0.00 | 38.00K | 47.00K | 976.00K | 202.00K | 227.00K | 60.00K | 0.00 | 0.00 | 4.44M | 15.86M | 0.00 | 0.00 | 0.00 |
| SG&A | 6.00M | 8.60M | 11.38M | 6.76M | 9.39M | 11.96M | 9.34M | 7.66M | 605.00K | 0.00 | 249.37M | 208.06M | 66.32M | 34.84M | 43.08M |
| Other Expenses | 186.73M | 6.20M | 10.17M | 10.17M | 3.65M | 10.17M | 11.09M | 12.00M | 7.88M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 192.73M | 336.00M | 363.22M | 94.16M | 139.82M | 131.44M | 120.73M | 123.70M | 125.86M | 0.00 | 412.24M | 320.20M | 231.34M | 194.29M | 211.41M |
| Cost & Expenses | 659.12M | 740.74M | 991.97M | 616.48M | 468.93M | 520.43M | 379.84M | 150.61M | 172.23M | 0.00 | 817.67M | 748.80M | 540.40M | 534.33M | 521.84M |
| Interest Income | 1.57M | 2.20M | 3.58M | 721.00K | 2.60M | 678.00K | 400.00K | 73.00K | 861.00K | 0.00 | 384.00K | 495.00K | 283.04K | 159.67K | 0.00 |
| Interest Expense | 46.89M | 29.71M | 53.85M | 62.72M | 59.28M | 62.75M | 51.61M | 34.85M | 7.32M | 0.00 | 85.46M | 74.39M | 68.96M | 59.98M | 99.79M |
| Depreciation & Amortization | 67.66M | 65.58M | 62.97M | 51.24M | 46.79M | 44.02M | 41.50M | 42.34M | 44.86M | 0.00 | 96.57M | 95.97M | 63.36M | 95.41M | 107.43M |
| EBITDA | -82.73M | -151.60M | -328.39M | -169.56M | -182.65M | -93.71M | -85.14M | -83.27M | -110.95M | 0.00 | -13.50M | 71.45M | 20.72M | -281.28M | 92.54M |
| EBITDA Ratio | -16.41% | -29.08% | -55.01% | -43.61% | -77.45% | -25.41% | -28.65% | -467.64% | -881.49% | 0.00% | -1.91% | 9.89% | 4.48% | 83.26% | 18.25% |
| Operating Income | -151.96M | -219.39M | -394.94M | -236.65M | -240.96M | -152.32M | -127.14M | -160.49M | -163.20M | 0.00 | -193.40M | -98.90M | -146.80M | -435.39M | -114.68M |
| Operating Income Ratio | -30.14% | -42.08% | -66.15% | -61.30% | -102.17% | -41.02% | -50.04% | -946.69% | -1,265.54% | 0.00% | -27.33% | -13.65% | -31.75% | -85.04% | -22.62% |
| Total Other Income/Expenses | -45.33M | -27.53M | -50.33M | -53.17M | -55.63M | -51.01M | -52.51M | -26.25M | 0.00 | 0.00 | -82.91M | -1.00K | -89.53M | -1.00 | -99.71M |
| Income Before Tax | -197.28M | -246.92M | -445.27M | -283.59M | -288.72M | -200.12M | -178.25M | -160.49M | -163.20M | 0.00 | -193.40M | -98.90M | -146.80M | -435.39M | -114.68M |
| Income Before Tax Ratio | -39.13% | -47.36% | -74.58% | -73.46% | -122.42% | -53.89% | -70.15% | -946.70% | -1,265.54% | 0.00% | -27.33% | -13.65% | -31.75% | -85.04% | -22.62% |
| Income Tax Expense | 0.00 | 913.00K | -64.00K | 16.33M | 8.92M | 13.26M | 12.45M | 12.55M | 9.24M | 0.00 | -19.02M | -32.08M | -90.12M | -9.11M | -12.78M |
| Net Income | -197.28M | -246.92M | -445.27M | -283.59M | -288.72M | -200.12M | -178.25M | -160.49M | -163.20M | 0.00 | -174.38M | -66.82M | -56.68M | -426.28M | -101.90M |
| Net Income Ratio | -39.13% | -47.36% | -74.58% | -73.46% | -122.42% | -53.89% | -70.15% | -946.70% | -1,265.54% | 0.00% | -24.64% | -9.22% | -12.26% | -83.26% | -20.10% |
| EPS | -9.15 | -11.45 | -20.65 | -14.45 | -16.04 | -12.03 | -12.97 | -11.28 | -12.06 | 0.00 | -17.70 | -7.13 | -6.05 | -50.74 | -13.95 |
| EPS Diluted | -9.15 | -11.45 | -20.65 | -14.45 | -16.04 | -12.03 | -12.97 | -11.28 | -12.06 | 0.00 | -17.70 | -7.13 | -6.05 | -50.74 | -13.95 |
| Weighted Avg Shares Out | 21.56M | 21.56M | 21.56M | 19.62M | 18.00M | 16.63M | 13.74M | 14.23M | 13.53M | 0.00 | 9.85M | 9.37M | 9.37M | 8.40M | 7.30M |
| Weighted Avg Shares Out (Dil) | 21.56M | 21.56M | 21.56M | 19.62M | 18.00M | 16.63M | 13.74M | 14.23M | 13.53M | 0.00 | 9.85M | 9.37M | 9.37M | 8.40M | 7.30M |
Source: https://incomestatements.info
Category: Stock Reports